Product Program year 2020 Source: CMS Open Payments

Belviq

Drug Nutrition and Weight Loss

NDC 62856-529-60

Open in the dashboard

General payments

$215,621

4,776 payments

Research payments

$5,756,683

522 payments

Through program year 2020, $215,621 in general payments and $5,756,683 in research payments were reported against Belviq (Nutrition and Weight Loss).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $11,125 4
2020 Research $1,834,234 173
2019 General $204,496 4,772
2019 Research $3,922,449 349

Breakdown

Who paid General payments · program years 2019–2020
  1. Eisai Inc. $215,621 4,776 payments
Top recipients General payments · program year 2020
  1. Alfred Neugut Medical Oncology · New York, NY $9,675 87% · 2 payments
  2. Gregory Holmes Neurology with Special Qualifications in Child Neurology · Burlington, VT $900 8% · 1 payment
  3. William Tamborlane Pediatric Endocrinology · New Haven, CT $550 5% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020
  1. Medical Oncology Internal Medicine $9,675 87% · 1 practitioner
  2. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $900 8% · 1 practitioner
  3. Pediatric Endocrinology Pediatrics $550 5% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. New York $9,675 87% · 1 recipient
  2. Vermont $900 8% · 1 recipient
  3. Connecticut $550 5% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

4,776 general · 522 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record